Sign in Create account

iSERA LIFESCIENCES LIMITED

Information Technology · IT - Software

BSE: 534920
₹143.90
▲ 0.00 (0.00%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
62/100
Moderate
Valuation
—/100
Expensive
Momentum
62/100
Neutral

QVM read Mixed signals Quality Moderate, Valuation Expensive, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹121 Cr
PE (TTM)
Data unavailable.
Price to Book
14.7
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
6997.8
Free Cash Flow
₹-5 Cr
as of March 31, 2026
Industry median ₹0 Cr (143 companies)
EPS Growth (YoY)
-3100.00%
as of June 30, 2026
Industry median -8.25% (122 companies)
Net Profit Growth (TTM)
-145.52%
as of June 30, 2026
Industry median 3.49% (121 companies)
Operating Revenue Growth (TTM)
6.39%
as of June 30, 2026
Industry median 8.06% (119 companies)
Profit Growth (YoY)
-2140.00%
as of June 30, 2026
Industry median 9.11% (122 companies)
Revenue Growth (YoY)
39.34%
as of Sept. 30, 2019
Industry median 9.67% (113 companies)
Current Ratio
6.63
as of March 31, 2026
Industry median 2.53 (141 companies)
Debt to Equity
0.00
as of March 31, 2026
Industry median 0.00 (129 companies)
Interest Coverage
14.78
as of Sept. 30, 2025
Industry median 17.20 (117 companies)
Net Margin
47.33%
as of March 31, 2026
Industry median 11.85% (119 companies)
Operating Margin (EBIT)
53.96%
as of March 31, 2026
Industry median 14.98% (120 companies)
Operating Margin (TTM)
0.46%
as of June 30, 2026
Industry median 15.28% (122 companies)
Return on Assets
2.46%
as of March 31, 2026
Industry median 5.12% (122 companies)
Return on Capital Employed
3.40%
as of March 31, 2026
Industry median 9.62% (121 companies)
Return on Equity
3.15%
as of March 31, 2026
Industry median 9.08% (123 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

2 of 6 met
  • No Net profit is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • Yes Debt to equity is below 0.5 (0.00)
  • No Return on equity is 15% or more (3.2%)
  • Yes Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

2 of 2 met
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

2 of 3 met
  • Yes 1-year return beats the industry median
  • Yes Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

1 of 5 met
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • Yes Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
0.0%
Low 143.9000 · High 143.9000
1W return
0.0%
Low 143.9000 · High 143.9000
1M return
0.0%
Low 143.9000 · High 151.0500
52W return
6988.7%
Low 143.9000 · High 151.0500
Lifetime High ₹151.0500 (Sept. 17, 2026)
Lifetime Low ₹0.5300 (March 15, 2019)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish5
Bearish1
5D
144.0
10D
143.5
20D
134.7
50D
95.8
100D
61.0
200D
20.4

Delivery and volume

Day avg. delivery
100.0%
Week avg. delivery
100.0%
Month avg. delivery
100.0%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

143.90
Pivot
First resistance143.90
Second resistance143.90
Third resistance143.90
First support143.90
Second support143.90
Third support143.90
Day RSI85.3
Day MFI93.5
Day MACD16.23
Day MACD signal21.30

Beta

1M—
3M0.00
1Y0.00
3Y0.00

Price change analysis

↑ 0.0%
Over 1 Month
LowHigh
143.90151.05
↑ 6988.7%
Over 3 Months
LowHigh
143.90151.05
↑ 6988.7%
Over 6 Months
LowHigh
143.90151.05
↑ 6988.7%
Over 1 Year
LowHigh
143.90151.05
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹— Cr
Net profit (June 30, 2026)
₹-0 Cr
Basic EPS (June 30, 2026)
₹-1.6000

Ranks #76 of 126 in IT - Software by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter58.63%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 58.63% in Jun 2026 qtr

Historical fii holding

Historical mutual fund holding

All shareholding details →

Deals (Bulk & Block)

All 46 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
17 Jun 2026 NEO APEX VENTURE LLP Bulk Sell 55,878 110.2900 BSE
17 Jun 2026 MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED Bulk Buy 56,456 110.2900 BSE
12 Feb 2024 RAMASAMY AZHAGAPPA SELVAN Bulk Buy 54,072 1.8500 BSE
12 Feb 2024 BRAHMAM SANNAMURI Bulk Sell 81,400 1.8500 BSE
15 Jan 2024 N L RUNGTA (HUF) Bulk Sell 98,096 1.8600 BSE
19 Dec 2022 LAXMANBHAI RAVJIBHAI GAJERA Bulk Buy 87,784 1.3000 BSE
19 Dec 2022 AJITKUMAR JOGENDARPRASAD SINGH Bulk Sell 127,683 1.3000 BSE
3 Apr 2017 NISHA YADAV Bulk Sell 111,728 2.6700 BSE
28 Mar 2017 NISHA YADAV Bulk Sell 83,463 2.7200 BSE
21 Feb 2017 NISHA YADAV Bulk Buy 2,000 3.6700 BSE

All bulk and block deals →

Corporate Actions

Full history (2 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
—NAME_CHANGEName changed from APTUS INDUSTRIES LTD. to COVIDH TECHNOLOGIES LIMITED
—NAME_CHANGEName changed from COVIDH TECHNOLOGIES LIMITED to iSERA LIFESCIENCES LIMITED

All corporate actions →

Corporate Announcements

All 7 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
1 Oct 2026 Company Update iSERA Lifesciences Ltd - 534920 - Announcement under Regulation 30 (LODR)-Allotment
1 Oct 2026 Others iSERA Lifesciences Ltd - 534920 - Board Meeting Outcome for Outcome Of The Board Meeting Of Isera Lifesciences Limited (Formerly Known As Covidh Technologies Limited) (The "Company") Held On October 01, 2026.
30 Sep 2026 AGM/EGM iSERA Lifesciences Ltd - 534920 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
29 Sep 2026 AGM/EGM iSERA Lifesciences Ltd - 534920 - Shareholder Meeting / Postal Ballot-Outcome of AGM
28 Sep 2026 Insider Trading / SAST iSERA Lifesciences Ltd - 534920 - Closure of Trading Window
5 Sep 2026 AGM/EGM iSERA Lifesciences Ltd - 534920 - Notice Of 34Th Annual General Meeting Of Isera Lifesciences Limited (Formerly Known As Covidh Technologies Limited) For The Financial Year 2025-26
5 Sep 2026 Others iSERA Lifesciences Ltd - 534920 - Reg. 34 (1) Annual Report.

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Strong net profit margin (47.3%)
  • Low financial leverage (Debt/Equity 0.00)
  • Comfortable interest coverage (14.8x)
  • Strong revenue growth YoY (39.3%)

Weaknesses

  • Low Return on Equity (3.2%)
  • Declining profit YoY (-2140.0%)

Opportunities

Data unavailable.

Threats

  • RSI in overbought territory (85.3)

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about iSERA LIFESCIENCES LIMITED

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.